Chun‐Ming Tsai
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 89
- Lung Cancer Diagnosis and Treatment 37
- Oncology top 0.2%
- Lung Cancer Research Studies 48
- Colorectal Cancer Treatments and Studies 27
- Peptidase Inhibition and Analysis 6
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 14
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 12
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Co-authors
- James Chih‐Hsin YangVera HirshTony MokSumitra ThongprasertLecia V. SequistWu‐Chou SuJoseph S. K. AuSarayut Lucien Geater
- Journals
- Journal of Clinical Oncology (21 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Chun‐Ming Tsai
111 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Pulmonary and Respiratory Medicine 6.4k
- Oncology 5.3k
- Cancer Research 1.4k
- Molecular Biology 2.0k
- Pathology and Forensic Medicine 394
Countries citing papers authored by Chun‐Ming Tsai
This map shows the geographic impact of Chun‐Ming Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Ming Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Ming Tsai more than expected).
Fields of papers citing papers by Chun‐Ming Tsai
This network shows the impact of papers produced by Chun‐Ming Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Ming Tsai. The network helps show where Chun‐Ming Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chun‐Ming Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 3 | |
| 5 | 2017 | 8 | |
| 6 | 2017 | 2 | |
| 7 | 2016 | 4 | |
| 8 | 2015 | 4 | |
| 9 | 2015 | 13 | |
| 10 | Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutationsbreakdown → | 2013 | 2461 |
| 11 | 2011 | 41 | |
| 12 | 2010 | 16 | |
| 13 | 2009 | 1 | |
| 14 | 2006 | 32 | |
| 15 | 2005 | 31 | |
| 16 | 2001 | 6 | |
| 17 | 2000 | 26 | |
| 18 | Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. | 1996 | 74 |
| 19 | 1995 | 3 | |
| 20 | 1990 | 10 |
About Chun‐Ming Tsai
Chun‐Ming Tsai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 114 papers that have together received 7.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (89 papers), Lung Cancer Research Studies (48 papers), Lung Cancer Diagnosis and Treatment (37 papers), Colorectal Cancer Treatments and Studies (27 papers), Cancer Genomics and Diagnostics (14 papers), Cancer therapeutics and mechanisms (12 papers), Peptidase Inhibition and Analysis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.4k citations), Oncology (5.3k citations) and Cancer Research (1.4k citations). Chun‐Ming Tsai has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include James Chih‐Hsin Yang, Vera Hirsh, Tony Mok, Sumitra Thongprasert, Lecia V. Sequist, Wu‐Chou Su, Joseph S. K. Au, Sarayut Lucien Geater, Michael Boyer and Martin Schüler. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.